Can you have PCOS without polycystic ovaries on ultrasound?

Yes. PCOS is diagnosed based on two of three criteria: irregular ovulation, clinical or biochemical signs of androgen excess, and polycystic ovaries on ultrasound. You can meet the diagnostic criteria with irregular periods and elevated androgens even if your ultrasound appears normal.

What is the difference between a normal ultrasound and a PCOS ultrasound?

A normal ultrasound typically shows fewer than 20 follicles per ovary, with one or two larger dominant follicles during the menstrual cycle. Ovarian volume is usually less than 10 mL. In PCOS, you see 20 or more small follicles (2-9 mm) arranged around the ovary's periphery, often with increased ovarian volume and brighter stromal tissue.

Is transvaginal or transabdominal ultrasound better for diagnosing PCOS?

Transvaginal ultrasound is the gold standard because it provides clearer, higher-resolution images of the ovaries. The probe is closer to the ovaries, allowing for more accurate follicle counting and volume measurement. Transabdominal ultrasound can be used in women who cannot undergo transvaginal imaging, but it is less precise and may miss smaller follicles.

Can birth control pills affect PCOS ultrasound results?

Yes. Hormonal contraceptives suppress ovarian activity, reducing the number of visible follicles and shrinking ovarian volume. If you've been on birth control, your ultrasound may appear normal even if you have underlying PCOS. For the most accurate assessment, ultrasound should be performed at least three months after stopping hormonal contraception.

Does having polycystic ovaries on ultrasound always mean you have PCOS?

No. Polycystic ovarian morphology is common in the general population, with studies showing that up to 20-30% of women without PCOS have polycystic-appearing ovaries on ultrasound. Diagnosis requires meeting at least two of the three Rotterdam criteria, which include irregular ovulation and signs of androgen excess in addition to ultrasound findings.

How often should ultrasound be repeated in women with PCOS?

Ultrasound is primarily a diagnostic tool and doesn't need to be repeated routinely once PCOS is diagnosed. However, it may be used to monitor ovarian response during fertility treatment or to evaluate for other conditions like ovarian cysts or endometrial thickness. Clinical symptoms and biomarkers like testosterone and insulin are more useful for tracking disease progression over time.

What Does PCOS Look Like on an Ultrasound?

Creator: Superpower
Published: 2026-03-05

Understand what your pcos results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Book your test

You've been told you might have PCOS, and now you're scheduled for an ultrasound. You know the scan is looking for something specific, but what exactly does polycystic ovary syndrome look like on imaging? The answer matters because ultrasound findings are only one piece of the diagnostic puzzle, and not every woman with PCOS will show the same pattern on the screen.

What polycystic ovaries actually look like on imaging

When a sonographer performs a pelvic ultrasound to evaluate for PCOS, they're looking at the size, shape, and internal structure of your ovaries. The hallmark finding is an increased number of small fluid-filled sacs called follicles, each measuring 2 to 9 millimeters in diameter. These follicles represent eggs at various stages of development that haven't matured or been released.

Current diagnostic criteria define polycystic ovarian morphology as 20 or more follicles visible in at least one ovary, or an ovarian volume greater than 10 milliliters. This threshold was updated in the 2018 international evidence-based guidelines from the older Rotterdam criteria, which used 12 follicles as the cutoff. The change reflects improvements in ultrasound technology that allow for more precise follicle counting.

The follicles in PCOS often arrange themselves in a characteristic pattern around the periphery of the ovary, creating what clinicians call the "string of pearls" sign. This describes the visual appearance of multiple small, evenly sized follicles lined up along the outer edge of the ovary, resembling beads on a necklace. The central portion of the ovary, called the stroma, may appear brighter or more echogenic on ultrasound due to increased tissue density.

A normal ultrasound, by contrast, shows fewer follicles scattered throughout the ovary, with one or two dominant follicles that grow larger during each menstrual cycle. The ovaries are typically smaller in volume, and the stromal tissue appears less prominent.

How PCOS affects ovarian structure and hormone production

The ultrasound findings in PCOS reflect what's happening at a hormonal and metabolic level. In a typical menstrual cycle, the pituitary gland releases follicle-stimulating hormone (FSH), which prompts several follicles to begin maturing. One follicle becomes dominant, grows larger, and eventually releases an egg during ovulation. The remaining follicles shrink away.

In PCOS, hormonal imbalances disrupt this process. Elevated luteinizing hormone (LH) relative to FSH, combined with insulin resistance and excess androgens, prevent follicles from maturing properly. Instead of one follicle reaching full size, many remain arrested at an early stage, creating the accumulation of small follicles visible on ultrasound.

Stromal expansion and androgen production

The increased ovarian volume seen in PCOS results from both the higher follicle count and the expansion of stromal tissue. The stroma produces androgens, and in PCOS, this tissue becomes more active and prominent. The bright or hyperechoic appearance of the stroma on ultrasound correlates with increased androgen production, which contributes to symptoms like acne, excess hair growth, and scalp hair thinning.

Metabolic feedback loops

This structural change also affects metabolic function. The ovaries in PCOS are more insulin-sensitive than in women without the condition, meaning elevated insulin levels directly stimulate androgen production. This creates a feedback loop where insulin resistance worsens hormonal imbalance, which in turn affects ovarian structure and function.

What drives the ultrasound findings in PCOS

Insulin resistance

When cells become less responsive to insulin, the pancreas compensates by producing more. Elevated insulin stimulates the ovaries to produce excess androgens, which interfere with normal follicle development and contribute to the accumulation of small follicles.

Androgen excess

High levels of testosterone and other androgens prevent follicles from maturing and ovulating, leading to the buildup of arrested follicles that characterize polycystic ovarian morphology. Women with higher androgen levels tend to have more pronounced ultrasound findings, including larger ovarian volume and more visible follicles.

LH to FSH ratio imbalance

In PCOS, LH levels are often disproportionately high compared to FSH. This hormonal imbalance favors androgen production over estrogen and disrupts the normal selection of a dominant follicle. The result is multiple small follicles that remain visible on ultrasound rather than progressing through the typical cycle.

Genetic predisposition

PCOS runs in families, and certain genetic variants affect how the ovaries respond to hormonal signals. Some women are predisposed to developing polycystic ovaries even with relatively mild metabolic disturbances, while others may have significant insulin resistance without the characteristic ultrasound findings.

Body composition

Adipose tissue, especially visceral fat, produces inflammatory cytokines and affects insulin sensitivity. Women with higher body fat percentages are more likely to have insulin resistance, which in turn drives the hormonal and structural changes visible on ultrasound. However, lean women with PCOS can also show polycystic ovarian morphology, indicating that weight is a contributing factor but not the sole determinant.

Why ultrasound findings vary between women with PCOS

Not every woman diagnosed with PCOS will have polycystic ovaries on ultrasound, and not every woman with polycystic ovaries has PCOS. This variability reflects the heterogeneity of the condition and the limitations of using imaging alone for diagnosis.

Age and developmental stage

Younger women, particularly adolescents, naturally have more follicles visible on ultrasound as part of normal ovarian development. This is why ultrasound is not recommended as a diagnostic criterion for PCOS in adolescents. The threshold of 20 follicles was established based on studies of adult women using high-resolution transvaginal ultrasound, and applying the same standard to younger populations leads to overdiagnosis.

Imaging technology and technique

Transvaginal ultrasound, which places the probe inside the vagina closer to the ovaries, provides much clearer images than transabdominal ultrasound. Older ultrasound machines or lower-frequency probes may miss smaller follicles, leading to undercounting. This is why the 2018 guidelines increased the follicle threshold from 12 to 20, accounting for improved imaging technology that can detect more follicles.

Hormonal contraceptive use

Birth control pills suppress ovarian activity, reducing the number of visible follicles and shrinking ovarian volume. Women who have been on hormonal contraception may have a normal-appearing ultrasound even if they have underlying PCOS. For this reason, ultrasound assessment is most accurate when performed after discontinuing hormonal contraception for at least three months.

Metabolic phenotype

Women with PCOS and significant insulin resistance tend to have more pronounced ultrasound findings, including higher follicle counts and larger ovarian volume. Those with milder metabolic disturbances may have borderline or normal-appearing ovaries despite meeting other diagnostic criteria for PCOS.

Ethnicity and genetic background

Studies have shown that the threshold for polycystic ovarian morphology may differ across populations. For example, some research suggests that women of South Asian descent may have higher baseline follicle counts, which could affect the interpretation of ultrasound findings in this population.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Connecting ultrasound findings to broader metabolic health

Ultrasound provides a snapshot of ovarian structure, but the real value comes from interpreting those findings alongside other biomarkers. Women with polycystic ovaries on ultrasound often have elevated insulin levels, even if fasting glucose appears normal. Measuring fasting insulin or calculating the HOMA-IR score can reveal insulin resistance that drives both the ultrasound findings and metabolic risk.

Testosterone and other androgens are central to PCOS diagnosis. Free testosterone, DHEA-S, and androstenedione levels help confirm hyperandrogenism when clinical signs like acne or hirsutism are present. Pairing ultrasound findings with androgen testing provides a more complete picture than either measure alone.

FSH and LH levels add context to ovarian morphology. An elevated LH to FSH ratio supports the diagnosis of PCOS and helps explain why follicles aren't maturing. Tracking these hormones over time can also show whether interventions are restoring more normal ovarian function.

Hemoglobin A1c and fasting glucose assess long-term blood sugar control. Women with PCOS are at higher risk for prediabetes and type 2 diabetes, and metabolic markers often worsen before ultrasound findings change. Monitoring glucose metabolism helps catch progression early.

Lipid panels, including triglycerides and HDL cholesterol, reflect cardiovascular risk. PCOS is associated with dyslipidemia, and tracking lipid markers alongside ultrasound findings helps assess overall metabolic health. The triglyceride-to-HDL ratio is particularly useful as a marker of insulin resistance.

If you're navigating PCOS, Superpower's 150+ biomarker panel can show you exactly where your hormones, metabolism, and ovarian function stand, so you're making decisions based on data, not guesswork.

Frequently Asked Questions

An ultrasound should be paired with blood tests for testosterone, SHBG, LH, FSH, fasting insulin, fasting glucose, and anti-Müllerian hormone (AMH) to complete the PCOS picture. An elevated LH/FSH ratio reflects the hormonal imbalance that causes follicle arrest; high AMH indicates excess small follicles consistent with polycystic ovarian morphology; free testosterone surfaces androgen excess that drives symptoms; and fasting insulin with fasting glucose assesses the insulin resistance underlying the structural changes. These biomarkers support clinical assessment, and a healthcare provider interprets results in context.

The string-of-pearls pattern forms because elevated insulin and LH prevent follicles from maturing past the 2–9 mm stage, causing them to accumulate in a ring around the ovarian periphery. Normally, FSH selects one dominant follicle to grow and ovulate; in PCOS, the LH:FSH ratio is skewed and excess insulin stimulates androgen production, arresting follicle development before any can ovulate. The expanded, hyperechoic stroma between follicles reflects increased androgen-producing tissue. The pattern and severity vary by individual androgen levels and insulin sensitivity.